Case report: Immune-mediated meibomian gland dysfunction following pembrolizumab therapy for advanced urothelial carcinoma

Ocular immune-related adverse events are a relatively rare complication of immune checkpoint inhibitors. Common ocular toxicities range from dry eyes to inflammatory uveitis and ocular myasthenia gravis. Here, we present the case of a 55-year-old woman with recurrent urothelial carcinoma of the uret...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Charles B., Su, Christopher T., Morgan, Meredith, Alva, Ajjai S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582237/
https://www.ncbi.nlm.nih.gov/pubmed/36276085
http://dx.doi.org/10.3389/fonc.2022.1000023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582237/
https://www.ncbi.nlm.nih.gov/pubmed/36276085
http://dx.doi.org/10.3389/fonc.2022.1000023

Ejemplares similares